The following is a summary of “Cytokeratin 17 activates AKT signaling to induce epithelial-mesenchymal transition and promote bladder cancer progression,” published in the April 2025 issue of BMC ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

UroGen Pharma's potential remains strong despite market volatility, with promising FDA prospects for UGN-102 & a $5B ...

Delays in initiating neoadjuvant chemotherapy (NAC) after TURBT for muscle-invasive bladder cancer and in performing radical cystectomy after completing NAC are associated with worse survival ...

Background/Objectives: Conventional transurethral resection of bladder tumor (TURBT) for non-muscle invasive bladder cancer (NMIBC) is usually performed in a piecemeal manner, leading to difficulties ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. A person walks on campus at University of ...

the use of mpMRI ahead of standard transurethral resection of bladder tumor (TURBT) reduced the time to correct treatment by a median of 45 days. This approach to initial staging made it possible ...

To evaluate the impact of discordant histological diagnoses between transurethral resection of bladder tumour (TURBT) and radical cystectomy (RC) on cancer-specific mortality (CSM) in patients with ...

“The positive data presented at EAU are compelling and suggest that bel-sar has the potential to introduce a new front-line focal treatment approach instead of or ahead of [transurethral resection of ...

Dosing was conducted 7 to 12 days before planned transurethral resection of bladder tumor (TURBT). In patients with intermediate-risk disease, 4 of 5 patients demonstrated a complete response. There ...